Drug Safety
Rheumatology Round-Up with Drs. Kavanaugh & Cush
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.
New ACR RA Guidelines and Practice Changing Abstracts: RA Panel
Dr. Jonathan Kay leads an international panel on the new ACR RA guidelines and other practice-changing abstracts presented at the 2020 ACR annual meeting. Panelists include Dr.Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.
Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth
Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.
Adverse Events in Low-Dose Methotexate: Dr. Eric Dein
Dr. Eric Dein reviews abstract #2001 presented at the 2020 ACR annual meeting.
Dr. Tom Appleton and Dr. Peter Nash Highlight OA and PsA Studies
Dr. Janet Pope interviews Dr. Tom Appleton and Dr. Peter Nash about several osteoarthritis and psoriatic arthritis studies presented at the 2020 ACR annual meeting.
Dr. Ken Saag - RECIPE Study: MMF with Pegloticase
Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.
Mavrilimumab in Giant Cell Arteritis: Dr. Richard Conway
Dr. Conway discusses late-breaking abstract #L06 presented Monday at the ACR 2020 annual meeting.
Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis
Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.
Antimalarials and Retinopathy: Dr. Janet Pope
Dr. Janet Pope reviews abstract #1825 at the 2020 ACR annual meeting.
Axial Spondyloarthritis Agents: Dr Antoni Chan
Dr. Chan reviews several abstracts #1366, #1367 and #1364 at the 2020 ACR annual meeting.
Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop
OHSU's Dr. Kevin Winthrop discusses two issues -- steroids and vaccines -- by looking at abstracts #1014, #0632, #0634 and #1135 at ACR 2020.
A New Pathway in Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses a new pathway - the use of deucravacitinib - for the treatment of psoriatic arthritis (abstracts L03) at the ACR 2020 annual meeting.
Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway
Dr. Conway discusses ACR abstract #1445 presented Sunday at the ACR annual meeting.
Check on Pneumococcal Vaccination: Dr. Janet Pope
Dr. Janet Pope reviews abstracts #0456 and #0457 presented at the 2020 ACR annual meeting.
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Poster Hall